Erudio Healtherudio.com
Sponsor
Fox Chase Cancer Center trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Fox Chase Cancer Center yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by Fox Chase Cancer Center: IMPROEV, RETAIN and RETAIN-3. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Fox Chase Cancer Center). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| RETAIN NCT02710734 · Fox Chase Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| IMPROEV NCT07221942 · Fox Chase Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| RETAIN-3 NCT07908979 · Fox Chase Cancer Center FocusedView → | muscle-invasive bladder urothelial carcinoma | Phase 2 | Focused | View | |||